While previous studies using Gas6−/− mice suggest that such inhibitors may be of therapeutic use in some renal pathology this article and previous work on Axl in VC [7], [8], [9], [10] indicate that such inhibitors should be studied in humans with caution, particularly in patients with renal disease. The gene discussed is GAS6; the disease is kidney disorder.